Showing results (11-20 of 95) with videos related to
Sort By:
Pageof 10
Oncotarget|February 13, 2016
Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinomaLorena Incorvaia, Giuseppe Bronte, Viviana Bazan, et al.International Medical Case Reports Journal|June 6, 2017
Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case reportElisabetta Gambale, Consiglia Carella, Paolo Amerio, et al.Journal of Cancer|May 23, 2015
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic reviewAntonino Grassadonia, Marta Caporale, Nicola Tinari, et al.Biochimica Et Biophysica Acta|September 23, 2008
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancerMarinella Zilli, Antonino Grassadonia, Nicola Tinari, et al.Trends in Immunology|June 20, 2002
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?Gabriel A Rabinovich, Linda G Baum, Nicola Tinari, et al.Anticancer Research|May 2, 2018
Relationship and Predictive Role of the Dual Expression of FGFR and IL-8 in Metastatic Renal Cell Carcinoma Treated with Targeted AgentsRoberto Iacovelli, Michele DE Tursi, Claudia Mosillo, et al.Clinical Colorectal Cancer|June 15, 2012
Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practiceCorrado Ficorella, Gemma Bruera, Katia Cannita, et al.Case Reports in Oncological Medicine|July 30, 2019
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease ProgressionMarta Peri, Antonino Grassadonia, Laura Iezzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinomaMauro Piantelli, Stefano Iacobelli, Giovanni Almadori, et al.Journal of Experimental & Clinical Cancer Research : CR|January 21, 2014
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic reviewIsabella Sperduti, Patrizia Vici, Nicola Tinari, et al.Pageof 10